Evidence map›Paper›PMID 40701999›Full record

ArticleNature communications2025

The histone H3 lysine 36 demethylase KDM2A/FBXL11 controls Polycomb-mediated gene repression and germ cell development in male mice.

Michael T Bocker, Grigorios Fanourgakis, Kristie Wetzel, Pavel A Komarov, Hélène Royo, Alexia Rohmer, Sunwoo Chun, Ching-Yeu Liang, Hubertus Kohler, Taiping Chen and 9 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Michael T Bocker *Discovery Sciences, Novartis Biomedical Research, Cambridge, MA, USA.
Grigorios Fanourgakis *Friedrich Miescher Institute for Biomedical Research (FMI), Basel, Switzerland.ORCID http://orcid.org/0000-0003-4971-0786
Kristie WetzelDisease Area X (DAx), Novartis Biomedical Research, Cambridge, MA, USA.
Pavel A KomarovFriedrich Miescher Institute for Biomedical Research (FMI), Basel, Switzerland.ORCID http://orcid.org/0000-0001-9482-0349
Hélène RoyoFriedrich Miescher Institute for Biomedical Research (FMI), Basel, Switzerland.
Alexia RohmerFriedrich Miescher Institute for Biomedical Research (FMI), Basel, Switzerland.
Sunwoo ChunFriedrich Miescher Institute for Biomedical Research (FMI), Basel, Switzerland.
Ching-Yeu LiangFriedrich Miescher Institute for Biomedical Research (FMI), Basel, Switzerland.
Hubertus KohlerFriedrich Miescher Institute for Biomedical Research (FMI), Basel, Switzerland.
Taiping ChenDiscovery Sciences, Novartis Biomedical Research, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-2524-6440
Xiaohong MaoDisease Area X (DAx), Novartis Biomedical Research, Cambridge, MA, USA.
Mark A LabowDiscovery Sciences, Novartis Biomedical Research, Cambridge, MA, USA.
Reginald A ValdezDiscovery Sciences, Novartis Biomedical Research, Cambridge, MA, USA.
Michael B StadlerFriedrich Miescher Institute for Biomedical Research (FMI), Basel, Switzerland.ORCID http://orcid.org/0000-0002-2269-4934
Dirk G de RooijReproductive Biology Group, Division of Developmental Biology, Department of Biology, Faculty of Science, Utrecht University, Utrecht, the Netherlands.
Paola CapodieciDisease Area X (DAx), Novartis Biomedical Research, Cambridge, MA, USA.
John TallaricoDiscovery Sciences, Novartis Biomedical Research, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-8040-8422
Antoine H F M PetersFriedrich Miescher Institute for Biomedical Research (FMI), Basel, Switzerland. antoine.peters@fmi.ch.ORCID http://orcid.org/0000-0002-0311-1887
Thomas B NicholsonDisease Area X (DAx), Novartis Biomedical Research, Cambridge, MA, USA. thomas.nicholson@novartis.com.ORCID http://orcid.org/0000-0001-7555-9456

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) NRP 63 - Stem Cells and Regenerative Medicine
6 · The paper itself

Abstract

KDM2A/FBXL11 is a Jumonji-domain containing lysine demethylase catalyzing the removal of mono- and di-methyl modifications of histone H3 lysine 36 (H3K36me1/2). While Kdm2a is required for mouse embryogenesis, its role in adult physiology has been largely unexplored. Using conditional deletion approaches, we demonstrate that Kdm2a deficiency leads to testicular atrophy and male infertility. Although spermatogonial stem cells remain unaffected, proliferating and differentiating spermatogonia exhibit delayed cell cycle progression and apoptosis. RNA-sequencing of purified spermatogonia and spermatocytes reveals Kdm2a-dependent repression of over 750 genes during spermatogonial differentiation. Chromatin immunoprecipitation followed by sequencing (ChIP-seq) demonstrates increased H3K36me2 levels at CpG-rich gene promoters in Kdm2a-deficient spermatogonia. KDM2A is required for Polycomb-mediated repression as shown by increased H3K36me2 and reduced H3K27me3 promoter occupancies and failed gene repression in Kdm2a deficient differentiating spermatogonia. Loss of Kdm2a in spermatocytes disrupts progression through meiotic prophase, as evidenced by impaired completion of chromosome synapsis and processing of meiotic double-strand breaks (DSBs), by altered chromatin states and by an impairment of X-linked gene repression. Our study thus identifies critical roles for KDM2A in coordinating gene expression programs during spermatogonial differentiation and meiosis, which are essential for male germ cell development.

Indexed as

F-Box ProteinsHistonesJumonji Domain-Containing Histone DemethylasesPolycomb-Group ProteinsAnimalsApoptosisCell DifferentiationInfertility, MaleLysineMaleMeiosisMiceMice, Inbred C57BLMice, KnockoutPromoter Regions, GeneticSpermatocytesF-Box ProteinsFBXL11 protein, mouseHistonesJumonji Domain-Containing Histone DemethylasesLysinePolycomb-Group Proteins

Identifiers

PMID40701999
PMCPMC12287389

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.